trial

iTBS to Enhance Social Cognition in People With Psychosis

NCTId NCT06118268
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 100 (estimated)
Sponsored by Northwell Health, Early Treatment Program at Lenox Hill
Primary completion 2027-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
100 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2023-04-18
Primary completion
2027-04
Eligibility
ALL · 18 Years · 39 Years

Interventions & indications

Drugs
iTBS (Active)

Sponsors

Northwell Health, Early Treatment Program at Lenox HillLead Sponsor
Wellcome TrustCollaborator
Centre for Addiction and Mental HealthCollaborator
University of Maryland, Baltimore CountyCollaborator

Sites

1 total
Glen Oaks, United States

Facts & assertions

4 sourced
Enrollment
100
Phase
NA
Primary Completion Date
2027-04
Status
RECRUITING
relationships
The graph out of here
drug
iTBS (Active)
drug
lead_sponsor
Northwell Health, Early Treatment Program at Lenox Hill
company
collaborator
Wellcome Trust
company
Centre for Addiction and Mental Health
company
indication
Schizo Affective Disorder
indication
Schizophreniform Disorders
indication
Psychotic Disorders
indication